Collaborative Study Group:Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes .Prospective Diabetes Study Group . Intensive blood-glucose control with sulphonylureas or insulin compar ......